CareCloud Inc (NAS:CCLD)
$ 2.42 -0.05 (-2.02%) Market Cap: 39.24 Mil Enterprise Value: 46.26 Mil PE Ratio: 0 PB Ratio: 0.90 GF Score: 71/100

Q2 2024 CareCloud Inc Earnings Call Transcript

Aug 13, 2024 / 12:30PM GMT
Release Date Price: $2.3 (+12.75%)

Key Points

Positve
  • CareCloud Inc (CCLD) reported positive GAAP net income for the first time since 2022, indicating improved profitability.
  • The company successfully reduced its line of credit balance from $10 million to $2.5 million, enhancing financial flexibility.
  • CareCloud's cirrusAI Notes, a new AI product, has received positive feedback from pilot users, highlighting its efficiency and accuracy in clinical documentation.
  • Revenue from the CareCloud Wellness program, including chronic care management and remote patient monitoring, increased by 154% year-over-year.
  • The company identified over $26 million in annualized cost savings, contributing to improved free cash flow and reduced operating expenses.
Negative
  • CareCloud Inc (CCLD) experienced a year-over-year revenue decline of $1.3 million, primarily due to softness in the medSR professional services business.
  • Despite positive feedback, the adoption of CareCloud cirrusAI Notes is still in its early stages, with only a small subset of clients currently using it.
  • The company faces challenges in expanding its medSR services due to market dominance by a few large players, limiting growth opportunities.
  • CareCloud Inc (CCLD) is still working on convincing clients of the value of its AI solutions, indicating potential hurdles in widespread adoption.
  • The company has not yet resumed dividends on its preferred stock, which may be a concern for some investors.
Operator

Ladies and gentlemen, welcome to the CareCloud second quarter 2024 results conference call. (Operator Instructions) As a reminder, this conference is being recorded.

I will now turn the call over to Kristen. Thank you. You may begin.

Unidentified_1

Good morning, everyone. Welcome to CareCloud's Second Quarter 2024 Conference Call. On today's call are Mahmud Haq, our Founder and Executive Chairman; Hadi Chaudhry, our Chief Executive Officer and Director; Stephen Snyder, our President; and Norman Roth, our Interim Chief Financial Officer and Controller.

Before we begin, I would like to remind you that certain statements made during this conference call are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

All statements other than statements of historical fact made during this conference are forward-looking statements, including, without limitation, statements regarding our expectations and guidance for future financial and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot